Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk-Reply

Affiliations

¹ National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
³ National Cancer Institute, Bethesda, Maryland.

Comment

Sherif Mehralivand et al. JAMA Oncol. 2018.

. 2018 Nov 1;4(11):1625.

doi: 10.1001/jamaoncol.2018.4234.

¹ National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
² Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
³ National Cancer Institute, Bethesda, Maryland.

No abstract available

Comment on

A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification.
Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, Nix JW, Thomas JV, Gordetsky JB, Gaur S, Harmon SA, Siddiqui MM, Merino MJ, Parnes HL, Wood BJ, Pinto PA, Choyke PL, Turkbey B. Mehralivand S, et al. JAMA Oncol. 2018 May 1;4(5):678-685. doi: 10.1001/jamaoncol.2017.5667. JAMA Oncol. 2018. PMID: 29470570 Free PMC article.
Magnetic Resonance Imaging-Based Prediction of Prostate Cancer Risk.
Bianchi G, Sighinolfi MC, Rocco B. Bianchi G, et al. JAMA Oncol. 2018 Nov 1;4(11):1624-1625. doi: 10.1001/jamaoncol.2018.4221. JAMA Oncol. 2018. PMID: 30326051 No abstract available.